2015 Annual Meeting: http://www.aaoms.org/annual_meeting/2015/index.php

S233
Treatment of TMJ-related and Nonrelated Myofascial Pain and Dysfunction With Onabotulinumtoxin A in Patients With Chronic Migraine Encephalalgia

Friday, October 2, 2015
3:30 PM-4:30 PM
Location

145B (Walter E. Washington Convention Center)

TicketedThis is a Fee Ticket Session
Handouts
  • Hudson Tx of MPD with Botox - S233.pdf (2.0 MB)
    • Speaker:

    John-Wallace Hudson DDS
    Knoxville, TN, USA


    Audio File Recorded Presentation
    CDE/CME Offered: CDE/CME
    CE Credit Hours: 1.00

    Synopsis

    Migraine headaches are a recurrent neurological disorder. A subgroup of migraine patients suffers from chronic migraines, defined as migraine frequency greater than 15 episodes in a month. Some chronic migraine sufferers have the comorbidity of myofascial pain and dysfunction, and TMJ. The speaker's retrospective study looks at the effect of reducing MPD symptoms when treating chronic migraine encephalagia without aura.

    Learning Objectives
    1. Incorporate a new treatment modal in to their TMJ/MPD therapy; and
    2. Treat TMJ/MPD more comprehensively.

    ยป Back to: Clinical Courses